Skip to main content

Accenture fast-tracks Mankind Pharma digital transformation with data-driven cloud platform

Pharma courses

pharma courses

Accenture fast-tracks Mankind Pharma digital transformation with data-driven cloud platform

Accenture is now working with Mankind Pharma, India’s 4th largest pharmaceutical manufacturing company as per as per IQVIA, to speed up its digital transformation to become an intelligent enterprise, improving business agility, performance, and operational efficiency.

As part of the project, Accenture deployed a digital platform based on SAP S/4HANA, a Microsoft Azure cloud-based data lake and Tableau dashboards, providing cloud-based analytics to help Mankind Pharma get deeper insights into its global business operations and performance. The platform integrates data in real-time from multiple sources across the supply chain, workforce and sales to provide a consolidated view of market insights. This can help the management team make informed decisions around business strategy, planning and product development.

The project was completed remotely during the ongoing pandemic with no impact on business continuity.

Arjun Juneja, chief operating officer, Mankind Pharma said “Digitally transforming our business processes with support from Accenture has been key to unlocking value trapped within the organization, accelerating real time decision making and improving our product innovation lifecycle.” “We committed to product innovation so we can provide high quality and affordable pharmaceutical products to people across the world,” he added.

“Digital reinvention can not only help pharma companies deliver high-quality and hyper-personalized services, but also improve business performance and build resilience against future disruptions. We are focused on helping Mankind Pharma embrace change and emerge as a data-driven enterprise to enhance its customer-centricity bringing innovative offerings to market at a faster pace and scale for patients, said Rishabh Bindlish, India Life Sciences and global generics lead, Accenture.

  << Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Search this website